Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1437402 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $5.00Day −1.67%Mkt cap $1.2B1Y +18.5%Off 52W high −40.5%Vol (1Y) 61.8%
Daily closing price, split-adjusted to the current basis; 3y shown of 3,035 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest10.6% of sh out |
| Days to cover8.1d |
| 13F net flow (QoQ)+2.06% |
| Top-10 13F concentration60.0% |
| Next report (est.)2026-07-30 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$427.7M |
| Earnings (TTM)-$58.1M |
| ROE−36.2% |
| Net margin−15.1% |
| ROIC−11.5% |
| Debt / equity1.21× |
| Sales growth 3Y98.4% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−14.2% |
| 1Y+18.5% |
| 3Y+26.9% |
| 5Y+192.4% |
| 10Y−53.2% |
| Since incept. (ann.)−8.2% |
Price return through 2026-07-29 · series begins 2014-06-19. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)61.8% |
| Ann. volatility (3Y)72.8% |
| Sharpe (1Y)0.55 |
| Sharpe (3Y)0.48 |
| Max drawdown (1Y)−37.4% |
| Max drawdown (3Y)−66.3% |
| Beta (3Y vs SPY)1.01 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BlackRock, Inc. | 21.2M | $127M | 8.63% | +0.1% |
| MILLENNIUM MANAGEMENT LLC | 17.8M | $107M | 7.28% | +49.8% |
| STATE STREET CORP | 13.6M | $81M | 5.55% | +14.2% |
| VANGUARD CAPITAL MANAGEMENT LLC | 10.4M | $62M | 4.23% | new |
| JANUS HENDERSON GROUP PLC | 8.4M | $50M | 3.41% | −42.3% |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 8.2M | $49M | 3.33% | −12.4% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.7M | $40M | 2.72% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 6.0M | $36M | 2.45% | +3.1% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-04-30 | −$0.15 | — | $94.5M | +27.5% |
| 2025-12-31 | 2026-02-19 | — | — | $125.2M | +7.8% |
| 2025-09-30 | 2025-10-30 | $0.00 | — | $110.3M | +12.3% |
| 2025-06-30 | 2025-08-04 | −$0.08 | — | $97.7M | +33.4% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-07-30 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
Reportable 100%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
